{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:54:48Z","timestamp":1759694088052},"reference-count":25,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2014]]},"DOI":"10.1536\/ihj.13-216","type":"journal-article","created":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T19:09:44Z","timestamp":1394737784000},"page":"146-152","source":"Crossref","is-referenced-by-count":14,"title":["Change in Carotid Intima-Media Thickness in a High-Risk Group of Patients by Intensive Lipid-Lowering Therapy With Rosuvastatin"],"prefix":"10.1536","volume":"55","author":[{"given":"Hiroyoshi","family":"Yokoi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Nohara","sequence":"additional","affiliation":[{"name":"Federation of National Public Service Personnel Mutual Aid Associations, Hirakata Kohsai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsumasa","family":"Hata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Kaku","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Kawamori","sequence":"additional","affiliation":[{"name":"Sportology Center, Juntendo University Graduate School of Medicine, supported by High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Center for Clinical and Translational Research, Kyushu University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Kurabayashi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Biological Science, Gunma University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izuru","family":"Masuda","sequence":"additional","affiliation":[{"name":"Takeda Hospital, Medical Examination Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Hokko Memorial Clinic Caress Sapporo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Clinical Research Support Center, the University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Bioethics, Graduate School of Medicine, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Justification for Atherosclerosis Regression Treatment (JART) Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hirano M, Nakamura T, Kitta Y, <i>et al<\/i>. Short-term progression of maximum intima-media thickness of carotid plaque is associated with future coronary events in patients with coronary artery disease. Atherosclerosis 2011; 215: 507-12.","DOI":"10.1016\/j.atherosclerosis.2011.01.014"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mathiesen EB, Johnsen SH, Wilsgaard T, B\u00f8naa KH, L\u00f8chen ML, Nj\u00f8lstad I. Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Troms\u00f8 Study. Stroke 2011; 42: 972-8.","DOI":"10.1161\/STROKEAHA.110.589754"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Greenland P, Alpert JS, Beller GA, <i>et al<\/i>. 2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 2010; 122: e584-636.","DOI":"10.1161\/CIR.0b013e3182051bab"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37: 87-92.","DOI":"10.1161\/01.STR.0000196964.24024.ea"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bots ML. Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies. Curr Med Res Opin 2006; 22: 2181-90. (Review)","DOI":"10.1185\/030079906X148472"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Stein JH, Korcarz CE, Hurst RT, <i>et al<\/i>. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008; 21: 93-111. (Review)","DOI":"10.1016\/j.echo.2008.01.002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nohara R, Daida H, Hata M, <i>et al<\/i>. Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study. Circ J 2012; 76: 221-9.","DOI":"10.1253\/circj.CJ-11-0887"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kurabayashi M, Sakuma I, Kawamori R, <i>et al<\/i>. Can intensive lipid-lowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART study. J Atheroscler Thromb 2010; 17: 416-22.","DOI":"10.5551\/jat.2899"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Teramoto T, Sasaki J, Ueshima H, <i>et al<\/i>. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007; 14: 45-50. (Review)","DOI":"10.5551\/jat.14.45"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Joint committee with the guidelines subcommittee of the Japan Academy of Neurosonology for ultrasonic assessment of carotid artery disease and the subcommittee for research into methods of screening atherosclerotic lesions. Guidelines for ultrasonic assessment of carotid artery disease: preliminary report. Neurosonology 2002; 15: 20-33.","DOI":"10.2301\/neurosonology.15.20"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yanase T, Nasu S, Mukuta Y, <i>et al<\/i>. Evaluation of a new carotid intima-media thickness measurement by B-Mode ultrasonography using an innovative measurement software, intimascope. Am J Hypertens 2006; 19: 1206-12.","DOI":"10.1016\/j.amjhyper.2006.05.010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. G\u00fcvener N, T\u00fct\u00fcnc\u00fc NB, Oto A, Erb\u00e5s T. Major determinants of the carotid intima-media thickness in type 2 diabetic patients: age and body mass index. Endocr J 2000; 47: 525-33.","DOI":"10.1507\/endocrj.47.525"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kuller L, Borhani N, Furberg C, <i>et al<\/i>. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol 1994; 139: 1164-79.","DOI":"10.1093\/oxfordjournals.aje.a116963"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Paul TK, Srinivasan SR, Wei C, <i>et al<\/i>. Cardiovascular risk profile of asymptomatic healthy young adults with increased femoral artery intima-media thickness: The Bogalusa Heart Study. Am J Med Sci 2005; 330: 105-10.","DOI":"10.1097\/00000441-200509000-00001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation 2001; 104: 2815-9.","DOI":"10.1161\/hc4601.099486"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Oren A, Vos LE, Uiterwaal CS, Grobbee DE, Bots ML. Cardiovascular risk factors and increased carotid intima-media thickness in healthy young adults: the Atherosclerosis Risk in Young Adults (ARYA) Study. Arch Intern Med 2003; 163: 1787-92.","DOI":"10.1001\/archinte.163.15.1787"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Crouse JR 3rd, Raichlen JS, Riley WA, <i>et al<\/i>. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007; 297: 1344-53.","DOI":"10.1001\/jama.297.12.1344"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 2002; 106: 2055-60.","DOI":"10.1161\/01.CIR.0000034508.55617.65"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Espeland MA, O\u2019Leary DH, Terry JG, Morgan T, Evans G, Mudra H. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med 2005; 6: 3.","DOI":"10.1186\/1468-6708-6-3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Azen SP, Mack WJ, Cashin-Hemphill L, <i>et al<\/i>. Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation 1996; 93: 34-41.","DOI":"10.1161\/01.CIR.93.1.34"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Brugts JJ, Yetgin T, Hoeks SE, <i>et al<\/i>. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 2009; 338: b2376. (Review)","DOI":"10.1136\/bmj.b2376"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Teramoto T, Kashiwagi A, Mabuchi H. Status of lipid lowering therapy prescribed based on recommendations in the 2002 report of the Japan Atherosclerosis Society Guideline for diagnosis and treatment of hyperlipidemia in Japanese adults: A study of the Japan Lipid Assessment Program (J-LAP). Curr Ther Res 2005; 66: 80-95.","DOI":"10.1016\/j.curtheres.2005.04.004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Davidson MH, Maki KC, Pearson TA, <i>et al<\/i>. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol 2005; 96: 556-63.","DOI":"10.1016\/j.amjcard.2005.04.019"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/55\/2\/55_13-216\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T19:21:18Z","timestamp":1618600878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/55\/2\/55_13-216\/_article"}},"subtitle":["Subanalysis of the JART Study"],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.13-216","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"type":"print","value":"1349-2365"},{"type":"electronic","value":"1349-3299"}],"subject":[],"published":{"date-parts":[[2014]]}}}